id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4337-0007,FDA,FDA-2018-N-4337,"Prescription Drug User Fee Act of
2017; Electronic Submissions and Data
Standards; Public Meeting; Request
for Comments",Notice,Request for Comments,2022-01-27T05:00:00Z,2022,1,2022-01-27T05:00:00Z,,2022-01-27T14:51:45Z,2022-01570,0,0,0900006484f3c739
FDA-2018-N-4337-0006,FDA,FDA-2018-N-4337,"Prescription Drug User Fee Act of
2017; Electronic Submissions and Data Standards; Public Meeting; Request for Comments",Notice,Request for Comments,2021-01-15T05:00:00Z,2021,1,2021-01-15T05:00:00Z,,2021-01-15T17:00:32Z,2021-00831,0,0,09000064849f40d9
FDA-2018-N-4337-0005,FDA,FDA-2018-N-4337,"March 10 Through April 30, 2020, Public Meetings; Postponement,
Cancellation, or Remote Only",Notice,Announcement,2020-03-19T04:00:00Z,2020,3,2020-03-19T04:00:00Z,,2020-03-19T13:11:49Z,2020-05743,0,0,090000648445445e
FDA-2018-N-4337-0003,FDA,FDA-2018-N-4337,"Prescription Drug User Fee Act of 2017; Electronic Submissions and Data
Standards; Public Meeting; Request for Comments",Notice,Public Meetings,2020-02-05T05:00:00Z,2020,2,2020-02-05T05:00:00Z,2020-04-23T03:59:59Z,2020-02-06T02:04:04Z,2020-02163,0,0,090000648432b8cd
FDA-2018-N-4337-0001,FDA,FDA-2018-N-4337,"Prescription Drug User Fee Act of 2017; Electronic Submissions and Data
Standards; Announcement of Public Meeting; Request for Comments",Notice,Request for Comments,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-04-11T03:59:59Z,2019-04-03T01:05:21Z,2018-25958,0,0,090000648390c11d